Wednesday, 25 September 2013

Injectable (IV) B-17/Laetrile/Amygdalin


Injectable (IV) B-17/Laetrile/Amygdalin
In Mexico, vitamin B-17 in metabolic therapy is administered through intravenous injection for the initial 21 days (phase I) of treatment and then orally afterwards (Phase II – See Pages 31-32). Some companies carry the injectable form in 3 gram ampoules (see Contacts at the end of this booklet). They may also supply customers with the syringes if it is legal in the latter’s area. There are 10 vials per box. 6 to 9 grams per day are used for the first 21 days in the Oasis of Hope hospital. Dr. Harold Manner and Ernesto Contreras used this protocol. 
Injectable B-17 is also invariably administered along with the tissue penetrating agent dimethyl Sulfoxide (DMSO). (For information of how some doctors use DMSO see page29). Please Note: Clinical tests have repeatedly shown that vitamin B-17 is only truly effective when used in conjunction with pancreatic enzymes to break down the pericellular coating of the malignant cell. Vitamins A and E in their emulsified form, along with high doses of vitamin C, vitamin B-15, antioxidants, and other nutrients are then used in combination with B-17 to attack the cancer cell. Clinics administering

Metabolic Therapy to their patients always use these supplements.
*Manner, HW, Michaelson, TL, and DiSanti, SJ. “Enzymatic Analysis of Normal and Malignant Tissues.” Presented at the Illinois
State Academy of Science, April 1978. Also, Manner, HW, Michaelson, TL, and DiSanti, SJ, “Amygdalin, Vitamin A and Enzymes
Induced Regression of Murine Mammary Adenocarcinomas”, Journal of Manipulative and Physiological Therapeutics, Vol 1, No. 4,
December 1978. 200 East Roosevelt Road, Lombard, IL 60148 USA

 
RM3,125-00  
for 5 injections pax.

No comments:

Post a Comment